Syn-Med-Chemist-"Quintessential Synthetic Chemistry"---A Synthetic Chemist's Perception......
Wednesday, March 4, 2015
Alizé Pharma announces launch of AZP-531 Phase II trial in patients with Prader-Willi syndrome
Alizé Pharma announces launch of AZP-531 Phase II trial in patients with Prader-Willi syndrome
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment